Close

UPDATE: Piper Sandler Downgrades Tabula Rasa Healthcare (TRHC) to Neutral

Go back to UPDATE: Piper Sandler Downgrades Tabula Rasa Healthcare (TRHC) to Neutral

Tabula Rasa Healthcare (TRHC) PT Lowered to $43 at SVB Leerink

February 25, 2021 4:39 AM EST

SVB Leerink analyst Stephanie Davis lowered the price target on Tabula Rasa Healthcare (NASDAQ: TRHC) to $43.00 (from $47.00) while maintaining a Market Perform rating.... More

Cantor Fitzgerald Downgrades Tabula Rasa Healthcare (TRHC) to Neutral

February 24, 2021 11:21 AM EST

Cantor Fitzgerald analyst Steven Halper downgraded Tabula Rasa Healthcare (NASDAQ: TRHC) from Overweight to Neutral with a price target of $40.00.

For an analyst ratings summary and ratings history on Tabula Rasa Healthcare... More